Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

Figure 2

Kaplan-Meier five- and seven-year DFS analysis based on risk group (n = 26). The multivariable regression model revealed the independent prognostic value of age<10 years, M1 bone marrow and WBC count<100,000/mm3, defining the group with favorable outcome.

Back to article page